Session 3 Summary cards Flashcards
(18 cards)
Disorders that show anticipation.
- HD
- FraX
- DM1
- Dentatorubro-pallidoluysian atrophy
- SCA1
- SCA3
- SCA7
Examples of age related mosaicism. Cause.
Failure in DNA repair mechanism evidenced by NF2
Classic and mosaic forms are germline and have a higher frequency of frameshift mutations that somatic form - sporadic vestibular schwannoma.
Other examples: cancer, loss/gain of sex chromosomes with age.
Example of mutation with reduced penetrance
c.907_909 del, Glu303del in TOR1A causing early onset primary dystonia.
30% penetrance. OK if not symptoms by 28
Example of condition with reduced penetrance
Breast cancer due to BRCA1 mutation. 80% lifetime risk
Examples of sex-limiting genes.
LHCGR (2p16.3) precocious male puberty. Constiutive activation of LH receptor (hypermorph)
Blepharophimosis, ptosis and epicathis inverusus (BPES) Type 1 (3q22.3) FOLXL2 polyalanine expansion. Predominantly expressed in ovaries resulting in POI
Example of epistasis
Bombay phenotype.
Can lead to locus heterogenity. Same phenotype resulting from multiple genes, usually in same pathway.
Example of pleiotropy.
PKU
Phe –> Tyr –> Melanin
Increased Phe = PKU
Reduced Tyr = reduced melanin = albinism
Gene associated with XLD hypophosphatemia
PHEX (Xq22.1)
stimulates FGFR23 expression in bone and normal bone dev.
FGF23 inhibits phosphate reabsorption in kidney required for normal bone formation.
PHEX mutation leads to increase in FGF23 overactivity or means FGF23 is not broken down properly
Examples of XLD conditions, gene, locus
- XLD hypophosphataemia (PHEX, Xq22.1)
- Alport Syndrome (COL4A5, Xq22.3)
- Fragile X (FMR1, Xq27.3)
Examples of XLD conditions with male lethality gene, locus
- Intercontinentia pigmentia (IKBKG, Xq28)
- Rett syndrome (MECP2, Xq28, CDKL5, Xp22.5) FOXG1 causes congenital/earlier onset form at 14q12
- Oral-facial-digital syndrome 1 (OFD1 Xp22,2)
Example of XLD where males unaffected
Craniofrontonasal syndrome caused by mutations in ephrin gene (EFNB1, Xq13.1)
What makes the terms X-linked dominant/recessive difficult to use in practise? 5
- Does not capture variable expressivity of x-linked disorders
2) Does not take into account the multiple mechanisms that can result in disease expression in females
XLR disorders, gene, locus
- DMD/BMD/DMD-assiocated cardiomyopathy (dystrophin Xp21.1-2)
Causes of females affected with XLR
- XO
- Del of other allele
- Translocation/rearrangement disrupting XIC
- UPD
- Somatic mosaic
- Skewing
Mutation spectrum of DMD/BMD
Del/dup of 1 or more exons account for
65-70% of DMD
80-85% of BMD
Two hotspots:
1) 80% of dels in 44-53
2) 20% of dels in exons 2-20 (5’)
Duplication freqs are opposite
XLR disorders and proposed gene therapy treatments.
- DMD -
stop codon readthrough applicable to 15% patients
exon skipping therapy applicable to ~80% of DMD - Haemophilia A/B: IV adeno-associated viral vectors expressing Factor 8 or 9
AR disorder and proposed gene therapy treatments.
SMA:
1) 18mer ASO010-27 (ISIS-SMN) in phase III trials for SMA infant - splicing modifier
2) scAAV9 carrying WT SMN gene. AveXis in phase I trials.
Potential microRNA biomarkers for treatment monitoring via blood test
Examples of single gene haploinsufficient disorders, gene, locus
- Familial hyerptrophic cardiomyopathy/HCM
- MYH7 (14q11.2)
- TNNT2 (1q32.1)
- TNNT3 (11p15.5) - Dilated cardiomypathy - LMNA
- Alagille syndrome
- JAG1 (20p12.2)
- NOTCH2 (1p12) - Aniridia (11p13)
- GLUT1 deficiency syndrome (1p34.2)
- HNPP (PMP22, 17p12)